- Sedative: Nerolidol reduced locomotor activity and increased sleep time in rodent models, comparable to diazepam at sub-toxic doses (Binet et al., 2020).
- Skin penetration enhancer: Increases transdermal absorption of co-applied molecules by 2–10× in ex vivo skin models — critical for topical cannabis formulations.
- Antileishmanial: IC50 of 12.5 µg/mL against Leishmania amazonensis promastigotes; low mammalian cytotoxicity (Arruda et al., 2005).
- Antimalarial: Active against Plasmodium falciparum in vitro; potential adjunct compound for tropical disease research.
- Antifungal: Inhibited Trichophyton rubrum and Candida albicans growth in multiple in vitro studies.
- Cannabis concentration: 0.01–0.5% of dry flower; typically a secondary terpene, rarely dominant but bioactively relevant.
- Synergy with CBD topicals: Nerolidol as a formulation excipient significantly improves CBD skin penetration, relevant to pain creams and transdermal patches.
Chemical Profile & Properties
Nerolidol (3,7,11-trimethyl-1,6,10-dodecatrien-3-ol) is a naturally occurring sesquiterpene alcohol found in the essential oils of dozens of aromatic plants. It exists as two stereoisomers — cis-nerolidol and trans-nerolidol — both found in cannabis, though trans-nerolidol is more commonly reported on laboratory test results. The hydroxyl (alcohol) group in its molecular structure gives it amphiphilic properties that underpin both its membrane-disrupting antimicrobial action and its skin-penetration enhancement.
| Property | Value |
|---|---|
| Chemical class | Sesquiterpene alcohol (acyclic) |
| Molecular formula | C15H26O |
| Molecular weight | 222.37 g/mol |
| Boiling point | 122°C (252°F) at 2 mmHg; ~276°C atmospheric |
| Aroma profile | Fresh wood, bark, floral, green, jasmine, orange blossom |
| Cannabis concentration range | 0.01–0.50% (mg/g: 0.1–5.0) |
| Stereoisomers | cis- and trans-nerolidol; both present in cannabis |
| Natural abundance | Neroli, jasmine, ginger, lemongrass, lavender, tea tree, cannabis |
Mechanism of Action
Unlike beta-caryophyllene, nerolidol does not target a single well-characterized receptor. Its sedative effects are thought to involve modulation of GABA-A receptor activity (a mechanism shared with linalool) and possible interaction with serotonergic pathways, though the precise targets are still being elucidated. Its amphiphilic molecular structure — part hydrophilic (the alcohol group), part lipophilic (the terpene chain) — allows it to insert itself into lipid bilayers. This property drives both antimicrobial activity (disrupting microbial membranes) and skin penetration enhancement (transiently fluidizing the stratum corneum).
The skin-penetration enhancement mechanism is particularly well-characterized: nerolidol increases membrane fluidity by disrupting the highly ordered ceramide bilayer of the stratum corneum, the skin’s primary barrier. This creates transient hydrophilic pathways and enlarges lipid domains, allowing polar and non-polar drug molecules to diffuse more rapidly. For cannabis topicals, this means co-formulating CBD or THC with nerolidol can dramatically improve bioavailability at the target tissue.
Understanding how nerolidol compares to other sedative terpenes is useful — see our full terpene guide and effects library.
Clinical & Preclinical Research
| Condition / Application | Study | Dose / Model | Result | Evidence Quality |
|---|---|---|---|---|
| Sedation / Sleep | Binet et al., 2020 (Planta Med) | 400 mg/kg oral, mice | Reduced locomotor activity; increased NREM sleep time by ~32% | Moderate (preclinical) |
| Antileishmanial | Arruda et al., 2005 (Antimicrob Agents Chemother) | In vitro, IC50 12.5 µg/mL | Selective cytotoxicity vs. Leishmania promastigotes; selective index >10 | Strong (in vitro) |
| Antimalarial | Lopes et al., 1999 (Antimicrob Agents) | In vitro, P. falciparum | Inhibition of parasite growth at µg/mL concentrations | Moderate (in vitro) |
| Antifungal | Elaissi et al., 2012 (BMC Complementary Medicine) | In vitro MIC assay | MIC 0.6–2.5 mg/mL vs. Candida spp.; comparable to fluconazole in some isolates | Moderate (in vitro) |
| Skin penetration enhancement | Cal, 2006 (Eur J Pharm Biopharm) | Ex vivo human skin | 3–8× increase in permeation of model drug; dose-dependent; reversible | Strong (ex vivo) |
| Antibacterial | Saad et al., 2013 (Nat Prod Res) | In vitro disk diffusion | Activity vs. S. aureus, E. coli, P. aeruginosa; modest but consistent inhibition zones | Moderate (in vitro) |
| Anxiolytic | Silva Brum et al., 2001 (Phytomedicine) | 50–200 mg/kg, mice | Dose-dependent reduction in anxiety measures; sedation at high doses | Early (animal) |
Top Cannabis Strains Highest in Nerolidol
Nerolidol is a secondary terpene in most cannabis profiles, rarely the most abundant but often present at bioactively relevant concentrations. It tends to appear in cultivars with complex, multi-layered aromas — particularly those with woody, earthy, or floral finishes. Check individual COAs for batch-specific data. See our full strain database.
| Strain | Type | Nerolidol Range (%) | Other Key Terpenes | Effect Profile |
|---|---|---|---|---|
| Jack Herer | Sativa-dominant | 0.10–0.45 | Terpinolene, Myrcene, Ocimene | Creative, uplifting, focused |
| Blue Dream | Hybrid (Sativa-leaning) | 0.08–0.40 | Myrcene, Alpha-pinene, Caryophyllene | Balanced euphoria, mood lift, light body |
| Skywalker OG | Indica-dominant | 0.10–0.50 | Myrcene, limonene, Caryophyllene | Heavy sedation, pain, sleep |
| Chemdawg 91 | Hybrid | 0.08–0.35 | Myrcene, Caryophyllene, Limonene | Cerebral, euphoric, body relaxation |
| Island Sweet Skunk | Sativa-dominant | 0.12–0.48 | Terpinolene, Ocimene, Myrcene | Energetic, social, appetite |
| Trainwreck | Hybrid (Sativa-leaning) | 0.09–0.38 | Terpinolene, Myrcene, Ocimene | Euphoric, creative, moderate pain |
| Master Kush | Indica | 0.08–0.30 | Myrcene, Caryophyllene, Limonene | Relaxation, stress, insomnia |
| Pineapple Express | Hybrid (Sativa-leaning) | 0.07–0.32 | Myrcene, Caryophyllene, Ocimene | Uplifting, creative, mild relaxation |
| White Widow | Hybrid | 0.06–0.28 | Myrcene, Alpha-Pinene, Caryophyllene | Balanced, energetic, social |
Entourage Effect: Synergy with Other Terpenes & Cannabinoids
Nerolidol’s most commercially significant synergy is with CBD in topical formulations. Its sedative profile also stacks meaningfully with myrcene and linalool. Full entourage context available in our terpene guide.
| Partner Compound | Combined Effect | Mechanism | Clinical Relevance |
|---|---|---|---|
| CBD (topical) | Dramatically enhanced transdermal CBD bioavailability | Nerolidol fluidizes stratum corneum; CBD penetrates to deeper tissue layers | High — direct formulation application for pain creams/patches |
| Myrcene | Amplified sedation & sleep promotion | Both interact with GABA-A pathways and reduce CNS excitability | Moderate — evening/sleep formulations |
| Linalool | Enhanced anxiolysis & relaxation | Linalool (GABA-A) + nerolidol (serotonergic/GABA-A) dual sedation pathway | Moderate — anxiety and stress relief |
| Alpha-Pinene | Antimicrobial synergy for topical applications | Pinene disrupts bacterial cell walls; nerolidol disrupts membranes; complementary targets | Moderate — topical antimicrobial formulations |
| THC | Deeper physical sedation; possible sleep benefit | THC CB1 sedation + nerolidol autonomic sedation; behavioral synergy in animal models | Emerging — anecdotal support in indica cultivars |
Non-Cannabis Natural Sources of Nerolidol
- Neroli (bitter orange blossom, Citrus aurantium): 3–15% of essential oil; namesake source of the terpene
- Jasmine (Jasminum officinale): 5–12% of absolute; luxury perfumery base note
- Ginger (Zingiber officinale): 2–8% of essential oil; contributes to woody dry-down note
- Lemongrass (Cymbopogon citratus): 1–6% of essential oil
- Lavender (Lavandula angustifolia): 0.5–3% of essential oil
- Tea tree (Melaleuca alternifolia): 0.2–2% of essential oil
- Cannabis: 0.01–0.50% of dry flower weight; primarily found in complex aromatic cultivars
Frequently Asked Questions
What is nerolidol used for in cannabis?
Nerolidol is valued for its sedative and sleep-promoting properties, antimicrobial activity, and its unique ability to enhance skin absorption of other compounds. In cannabis it contributes to the calming, woodsy aroma of certain cultivars and may amplify the relaxing effects of myrcene and CBD. It is also being investigated as a skin-penetration enhancer for transdermal cannabis formulations.
What does nerolidol smell like?
Nerolidol has a complex, multi-layered aroma combining fresh woody bark, floral notes reminiscent of orange blossom and jasmine, and a subtle green, grassy undertone. In perfumery it is prized as a dry-down note that lingers and softens other sharper fragrances. In cannabis it emerges as a clean, woody-floral finish that moderates sharper citrus or fuel top-notes.
Does nerolidol have antimicrobial properties?
Yes. Multiple in vitro studies have demonstrated nerolidol activity against bacteria, fungi, parasites, and protozoa. It has shown antileishmanial and antimalarial activity in cell culture models, and inhibits common fungal pathogens including Candida albicans. Its antimicrobial mechanism involves disruption of microbial membrane integrity.
How does nerolidol enhance topical drug delivery?
Nerolidol acts as a penetration enhancer by disrupting the ordered lipid bilayer structure of the skin’s stratum corneum. This temporarily increases membrane fluidity and allows larger molecules — including CBD and other cannabinoids — to pass through the skin more efficiently. Studies have shown nerolidol can increase transdermal permeation of compounds by two- to ten-fold in ex vivo skin models, making it highly relevant for cannabis topicals and transdermal patches.